Siglec-8 as a Drugable Target to Treat Eosinophil and Mast Cell-Associated Conditions

Pharmacology and Therapeutics - United Kingdom
doi 10.1016/j.pharmthera.2012.06.005
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Elsevier BV